Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 1/20 | 0.74 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.74 |
| ▸ | RELA | Q04206 | 1/20 | 0.74 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.69 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.69 |
| ▸ | LTB4R | Q15722 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.57 |
| ▸ | FAAH | O00519 | 2/20 | 0.56 |
| ▸ | PPARG | P37231 | 4/20 | 0.56 |
| ▸ | TERT | O14746 | 3/20 | 0.56 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.56 |
| ▸ | PPARD | Q03181 | 3/20 | 0.56 |
| ▸ | PPARA | Q07869 | 3/20 | 0.56 |
| ▸ | TOP1 | P11387 | 3/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | BLM | P54132 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | FABP4 | P15090 | 2/20 | 0.56 |
| ▸ | GMNN | O75496 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9607132 | 0.91 | FFAR1 (0.84) | NFKB1NFKB2RELAFFAR1FFAR4 | |
| SCHEMBL9607153 | 0.90 | NFKB1 (0.66) | NFKB1NFKB2RELAFFAR1FFAR4 | |
| SCHEMBL31187216 | 0.89 | NFKB1 (0.86) | NFKB1NFKB2RELAFFAR1FFAR4 | |
| SCHEMBL16681060 | 0.89 | NFKB1 (0.86) | NFKB1NFKB2RELAFFAR1FFAR4 | |
| SCHEMBL7549870 | 0.88 | FFAR1 (0.89) | NFKB1NFKB2RELAFFAR1FFAR4 | |
| SCHEMBL9607098 | 0.88 | NFKB1 (0.62) | NFKB1NFKB2RELAFFAR1FFAR4 | |
| SCHEMBL7557663 | 0.88 | FFAR1 (0.89) | NFKB1NFKB2RELAFFAR1FFAR4 | |
| SCHEMBL18258551 | 0.88 | FFAR1 (0.89) | NFKB1NFKB2RELAFFAR1FFAR4 | |
| SCHEMBL9607135 | 0.86 | FFAR1 (0.67) | NFKB1NFKB2RELAFFAR1FFAR4 | |
| SCHEMBL16431123 | 0.86 | FFAR1 (0.80) | NFKB1NFKB2RELAFFAR1FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180196074-A1 | METHODS AND SYSTEMS FOR METABOLITE AND/OR LIPID-BASED DETECTION OF COLORECTAL CANCER AND/OR ADENOMATOUS POLYPS | Universal Diagnostics, S.A. (ES) | 2018-07-12 | — | — | US | disclosed |
| US-20170343567-A1 | METHODS AND SYSTEMS FOR METABOLITE AND/OR LIPID-BASED DETECTION OF COLORECTAL CANCER AND/OR ADENOMATOUS POLYPS | Universal Diagnostics, S.A. (ES) | 2017-11-30 | — | — | US | disclosed |
| US-20120136057-A1 | HYDROXY FATTY ACID COMPOUNDS AND USES THEREOF FOR DISEASE TREATMENT AND DIAGNOSIS | PHENOMENOME DISCOVERIES INC. (CA) | 2012-05-31 | — | — | US | disclosed |
| US-20120136057-A1 | HYDROXY FATTY ACID COMPOUNDS AND USES THEREOF FOR DISEASE TREATMENT AND DIAGNOSIS | PHENOMENOME DISCOVERIES INC. (CA) | 2012-05-31 | — | — | US | disclosed |
| WO-2011011882-A1 | HYDROXY FATTY ACID COMPOUNDS AND USES THEREOF FOR DISEASE TREATMENT AND DIAGNOSIS | PHENOMENOME DISCOVERIES INC. (CA) | 2011-02-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120136057-A1 | HYDROXY FATTY ACID COMPOUNDS AND USES THEREOF FOR DISEASE TREATMENT AND DIAGNOSIS | HCAR2, ALOX5, ALOX12 | NFKB1 514/4885NFKB2 245/4885RELA 240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.